Co-Diagnostics Inc (CODX)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

4049 SOUTH HIGHLAND DRIVE SALT LAKE CITY, UT 84124

Co-Diagnostics, Inc. operates as a molecular diagnostics company. The Company develops, manufactures, and sells reagents used for diagnostic tests that function via the detection and analysis of nucleic acid molecules, as well as offers diagnostic equipment from other manufacturers as self-contained lab systems. Co-Diagnostics markets its products worldwide.

Data as of 2020-11-22
Market Cap313.505 Million Shares Outstanding28.269 Million Avg 30-day Volume2.01 Million
P/E Ratio12.3 Dividend Yield EPS0.9
Price/Sales6.598 Price cash flow ratio41.8 Price free cash flow ratio56.6
Book Value1.87 Price to Tangible Book5.94 Alpha0.16
Short Interest Ratio % Short Interest to Float R-squared0.012934
BETA-1.5938 52-week High/Low30.99 / 0.86 Stddev0.694522

Are you looking for this stock instead?

View SEC Filings from CODX instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 80 88 -9.09% 14 (0.92%) 14 (0.91%) 0.0%
13F shares: 7.659 Million 6.68 Million 14.67% 1.41 Million 1.043 Million 35.2%
% Ownership 27.2748 24.3277 12.11% 5.0219 3.799 32.19%
New Positions: 15 51 -70.59% 5 8 -37.5%
Increased Positions 27 18 50.0% 3 4 -25.0%
Closed Positions 21 9 133.33% 5 2 150.0%
Reduced Positions 19 11 72.73% 4 2 100.0%
Total Calls 1.02 Million 1.617 Million -36.92% 205.4 Thousand 192.9 Thousand 6.48%
Total Puts 1.014 Million 899.619 Thousand 12.74% 138.2 Thousand 118.7 Thousand 16.43%
PUT/CALL Ratio 0.99 0.56 76.79% 0.67 0.62 8.06%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CODX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CODX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

134.4 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

177 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SERBIN RICHARD S

  • Director
17,000 2020-11-23 5

BENSON REED L CFO AND SECRETARY

  • Officer
0 2020-11-23 1

DURENARD EUGENE

  • Director
10,000 2020-11-23 5

EGAN DWIGHT H CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-11-20 1

NELSON JAMES B

  • Director
0 2019-09-03 0

MURPHY EDWARD L.

  • Director
0 2019-04-24 0

AMERICA 2030 CAPITAL, LLC

  • 10% Owner
0 2018-07-18 0

SATTERFIELD BRENT CHIEF SCIENCE OFFICER

  • Officer
  • Director
  • 10% Owner
2,275,000 2018-05-11 0

BORKOWSKI EDWARD

0 2017-07-11 0

KIESNER FRANK J

0 2017-07-11 0

LEGENDS CAPITAL GROUP, LLC

1,300,344 2017-07-11 0

REAGENTS, LLC

1,953,613 2017-07-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

EGAN DWIGHT H - Director - Officer CHIEF EXECUTIVE OFFICER

2020-11-25 08:56:17 -0500 2020-11-24 F 5,236 $1.10 d 44,764 direct -2.0593 0.0 1 -2.0593 2

EGAN DWIGHT H - Director - Officer CHIEF EXECUTIVE OFFICER

2020-11-25 08:56:17 -0500 2020-11-24 M 50,000 $1.10 a 50,000 direct -2.0593 0.0 1 -2.0593 2

EGAN DWIGHT H - Director - Officer CHIEF EXECUTIVE OFFICER

2020-11-25 08:56:17 -0500 2020-11-24 M 50,000 d 0 direct

EGAN DWIGHT H - Director - Officer CHIEF EXECUTIVE OFFICER

2020-11-25 08:56:17 -0500 2020-11-24 S 44,764 $10.51 d 0 direct -2.0593 0.0 1 -2.0593 2

SERBIN RICHARD S - Director

2020-11-24 17:36:02 -0500 2020-11-23 M 17,000 a 17,000 direct -2.0593 0.0 1 -2.0593 2

EGAN DWIGHT H - Director - Officer CHIEF EXECUTIVE OFFICER

2020-11-25 08:56:17 -0500 2020-11-23 M 80,000 d 50,000 direct

EGAN DWIGHT H - Director - Officer CHIEF EXECUTIVE OFFICER

2020-11-25 08:56:17 -0500 2020-11-23 F 8,431 $1.10 d 71,569 direct -2.0593 0.0 1 -2.0593 2

DURENARD EUGENE - Director

2020-11-24 17:37:52 -0500 2020-11-23 A 10,000 a 10,000 direct

SERBIN RICHARD S - Director

2020-11-24 17:36:02 -0500 2020-11-23 M 17,000 d 0 direct

EGAN DWIGHT H - Director - Officer CHIEF EXECUTIVE OFFICER

2020-11-25 08:56:17 -0500 2020-11-23 A 75,000 a 75,000 direct

EGAN DWIGHT H - Director - Officer CHIEF EXECUTIVE OFFICER

2020-11-25 08:56:17 -0500 2020-11-23 M 80,000 $1.10 a 80,000 direct -2.0593 0.0 1 -2.0593 2

DURENARD EUGENE - Director

2020-11-24 17:37:52 -0500 2020-11-23 M 10,000 a 10,000 direct -2.0593 0.0 1 -2.0593 2

SERBIN RICHARD S - Director

2020-11-24 17:36:02 -0500 2020-11-23 A 17,000 a 17,000 direct

EGAN DWIGHT H - Director - Officer CHIEF EXECUTIVE OFFICER

2020-11-25 08:56:17 -0500 2020-11-23 S 71,569 $10.44 d 0 direct -2.0593 0.0 1 -2.0593 2

DURENARD EUGENE - Director

2020-11-24 17:37:52 -0500 2020-11-23 M 10,000 d 0 direct

BENSON REED L - Officer CFO AND SECRETARY

2020-11-24 17:34:30 -0500 2020-11-23 A 27,500 a 27,500 direct

EGAN DWIGHT H - Director - Officer CHIEF EXECUTIVE OFFICER

2020-11-25 08:56:17 -0500 2020-11-20 F 1,983 $1.10 d 18,017 direct -2.0593 0.0 1 -2.0593 2

EGAN DWIGHT H - Director - Officer CHIEF EXECUTIVE OFFICER

2020-11-25 08:56:17 -0500 2020-11-20 M 20,000 d 130,000 direct

EGAN DWIGHT H - Director - Officer CHIEF EXECUTIVE OFFICER

2020-11-25 08:56:17 -0500 2020-11-20 M 20,000 $1.10 a 20,000 direct -2.0593 0.0 1 -2.0593 2

EGAN DWIGHT H - Director - Officer CHIEF EXECUTIVE OFFICER

2020-11-25 08:56:17 -0500 2020-11-20 S 18,017 $11.09 d 0 direct -2.0593 0.0 1 -2.0593 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments